TRISHA SMITH: Open Payments
NPI 1255737391 · AUBURN, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,072 in 49 payments from 15 companies in 2025. Trend: 2023 $899 · 2024 $822 · 2025 $1,072
Food & beverage: $1,072
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 9 | $271 |
| ABBVIE INC. | 11 | $153 |
| PFIZER INC. | 6 | $116 |
| Novo Nordisk Inc | 4 | $112 |
| Lilly USA, LLC | 5 | $95 |
| GlaxoSmithKline, LLC. | 2 | $47 |
| Abbott Laboratories | 2 | $43 |
| Aimmune Therapeutics, Inc. | 2 | $39 |
| Madrigal Pharmaceuticals | 1 | $34 |
| Agios Pharmaceuticals, Inc. | 1 | $34 |
Products named: Korlym, NURTEC ODT, LINZESS, MOUNJARO, Rybelsus, TRELEGY ELLIPTA, DALVANCE, PREVNAR 20.
Industry payments across CA — which companies pay providers there.
